Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

ICON stock price, quote, forecast and news

ICLR
IE0005711209
932242

Price

302.52
Today +/-
-4.94
Today %
-1.80 %
P

ICON stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the ICON stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the ICON stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the ICON stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze ICON's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

ICON Stock Price History

DateICON Price
9/6/2024302.52 undefined
9/5/2024308.00 undefined
9/4/2024312.52 undefined
9/3/2024312.22 undefined
8/30/2024322.06 undefined
8/29/2024320.58 undefined
8/28/2024320.74 undefined
8/27/2024326.01 undefined
8/26/2024322.97 undefined
8/23/2024324.16 undefined
8/22/2024320.32 undefined
8/21/2024323.13 undefined
8/20/2024323.99 undefined
8/19/2024324.91 undefined
8/16/2024322.49 undefined
8/15/2024321.53 undefined
8/14/2024317.42 undefined
8/13/2024320.34 undefined
8/12/2024311.72 undefined

ICON Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into ICON, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by ICON from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects ICON’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of ICON. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into ICON’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing ICON’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on ICON’s growth potential.

ICON Revenue, EBIT and net profit per share

DateICON RevenueICON EBITICON Net Income
2029e12.43 B undefined0 undefined2.11 B undefined
2028e11.76 B undefined2.47 B undefined2 B undefined
2027e10.98 B undefined2.28 B undefined1.8 B undefined
2026e10.02 B undefined2.02 B undefined1.62 B undefined
2025e9.38 B undefined1.86 B undefined1.45 B undefined
2024e8.68 B undefined1.7 B undefined1.27 B undefined
20238.12 B undefined1.05 B undefined612.34 M undefined
20227.74 B undefined866 M undefined505.3 M undefined
20215.48 B undefined607.9 M undefined153.2 M undefined
20202.8 B undefined409.6 M undefined332.3 M undefined
20192.81 B undefined433.4 M undefined374 M undefined
20182.6 B undefined385.9 M undefined322.7 M undefined
20171.76 B undefined346.1 M undefined281.5 M undefined
20161.67 B undefined319.9 M undefined262.2 M undefined
20151.58 B undefined281.5 M undefined239.5 M undefined
20141.5 B undefined211.2 M undefined172.5 M undefined
20131.34 B undefined130.2 M undefined102.8 M undefined
20121.12 B undefined73.6 M undefined55.4 M undefined
2011945.7 M undefined39.2 M undefined22.9 M undefined
2010900 M undefined92.1 M undefined87.1 M undefined
2009887.6 M undefined116.3 M undefined94.3 M undefined
2008865.2 M undefined99.5 M undefined78.1 M undefined
2007630.7 M undefined69.2 M undefined56 M undefined
2006455.6 M undefined47.8 M undefined38.3 M undefined
2005326.7 M undefined29.9 M undefined13.5 M undefined
2004296.9 M undefined34.4 M undefined25.7 M undefined

ICON Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0.010.010.010.020.030.050.060.080.120.160.230.30.330.460.630.870.890.90.951.121.341.51.581.671.762.62.812.85.487.748.128.689.3810.0210.9811.7612.43
--27.2757.1418.1873.0831.1135.5945.0034.4844.2331.5610.1439.5738.4637.302.541.475.0017.9919.8212.504.795.785.5247.618.09-0.2995.9241.264.906.858.146.799.587.105.66
63.6463.6450.0050.0046.1546.6747.4647.5044.8346.7945.7845.2745.0943.7443.8143.4742.7339.7835.2435.6136.6839.9242.2942.3241.5829.9429.6329.2827.5528.6529.66------
0.010.010.010.010.010.020.030.040.050.070.10.130.150.20.280.380.380.360.330.40.490.60.670.710.730.780.830.821.512.222.41000000
000000.010.010.010.010.020.020.030.030.050.070.10.120.090.040.070.130.210.280.320.350.390.430.410.610.871.051.71.862.022.282.470
18.1818.187.1418.183.8513.3311.8610.009.4811.5410.6711.498.9010.3310.9511.4513.0810.224.136.559.7314.0417.8419.1519.6814.8415.4414.6211.0811.1912.8719.5519.8320.1420.7820.97-
0000000.010.010.010.010.020.030.010.040.060.080.090.090.020.060.10.170.240.260.280.320.370.330.150.510.611.271.451.621.822.11
---100.00--100.00-25.0083.3327.2728.5738.89-48.00192.3147.3739.2920.51-7.45-74.71150.0085.4568.6338.959.627.2514.5916.15-11.23-53.92230.0721.19108.1713.9711.7810.7211.075.66
27.827.828.431.832.935.247.747.347.84948.754.856.657.759.560.259.960.661.160.562.363.160.356.454.854.854.353.368.182.582.72000000
-------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The ICON Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the ICON is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                       
6544848475518797882103119101194256174190321216190261360456570842754290380.06
0.010.020.030.030.050.070.120.130.140.130.20.280.350.280.270.330.40.460.520.580.610.650.780.951.141.972.692.74
03323254668817283222322333545358606463107112157.05
0000000000000000000000000000
2222258111413202130302735445453363534374253114137132.11
0.020.080.080.080.10.130.150.230.240.240.330.420.50.540.580.560.660.850.820.860.961.11.331.632.12.943.233.41
58161720254043454868133172179171168168161148150149163159270259535504501.52
000000000000000000000071020253346.8
00000000000350010102515111318201717192178.47
0000000000000.010.010.010.030.030.030.050.070.060.070.050.070.074.714.283.86
00000.010.010.050.060.070.070.080.120.170.170.180.250.320.360.460.590.620.770.760.880.949.048.979.02
000000000018101014811143338342328343311914873.66
0.010.010.020.020.030.040.090.110.110.110.150.270.370.370.370.470.540.590.710.850.871.051.021.281.3314.4513.9613.58
0.020.090.10.10.130.170.240.340.350.350.480.690.870.910.951.031.21.441.531.721.832.152.362.913.4317.3917.1916.99
                                                       
1111111122255555555555555776.7
00.050.050.060.060.060.060.110.110.120.130.140.160.170.20.210.240.280.330.380.440.480.530.580.626.736.846.94
0.010.010.020.020.040.050.070.090.110.110.150.210.290.380.470.480.520.620.660.440.590.740.891.111.261.421.822.43
00-1-3-5-281011315323130-16-92-38-66-90-43-74-81-40-91-172-143.51
0000000000000000000544455000
0.010.060.070.080.090.110.140.220.230.240.30.390.460.570.670.680.750.910.950.760.951.191.351.621.858.078.59.24
11123611131081013181212585379191324519181131.58
07881113230000010711691101129139167159135169172185186463440421.91
0.010.020.010.010.020.030.060.10.10.090.150.170.150.170.150.20.280.360.370.410.350.380.430.570.891.872.122.16
0000000000000000000000000000
11321112700554441000000000035005555110.15
0.010.020.020.020.040.060.10.120.110.10.170.230.320.30.250.310.410.50.540.570.490.570.611.131.122.482.692.83
000000000000.050.070000000.350.350.350.3500.355.384.63.67
000000000000.010.010.010.010.010.010.010.010.010.010.010.010.010.011.090.990.9
11111111111161924162721182729333332109103374409358.97
000000000000.070.10.040.030.040.030.030.040.380.390.390.390.120.466.8464.92
0.020.030.020.020.040.060.10.120.110.110.170.30.410.340.280.350.450.530.580.950.880.9611.251.599.328.697.75
0.030.090.10.10.130.170.230.340.350.350.480.690.870.910.951.031.21.441.531.721.832.152.352.873.4417.3917.1916.99
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of ICON provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand ICON's financial health and stability.

Assets

ICON's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that ICON must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of ICON after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into ICON's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199519961997199819992000200120022003200420052005200620072008200920102011201220132014201520162017201820192020202120222023
2204861114182513738567894872255102172239262281322375333153505612
00012356711138141927323338424652575961666166315569585
00-1000000100-1-12-32-6-10-10-731101-10-60-125-85
000-3-8-1-17-3-46-12-8-5-37-33124-43-441468-69-54-1030-150-82108135-550-114
00100000001164612141418232845667959608685420234218
00000000000001530000021313131313106210317
00040202755411131913142218141714101218292755116163
000000.01-00.020.020.040.030.010.050.040.080.260.090.020.110.220.170.280.260.380.270.410.570.830.561.16
-2-2-2-4-9-5-6-10-15-13-15-12-31-75-67-33-31-35-30-29-32-49-42-44-48-50-51-93-142-140
-2-2-2-4-457-224-35-47-25-16-55-118-117-6514-152-121-184-112-204-74-177-37-162-46-6,024-145-226
0000-3513-1515-19-34-9-4-23-43-49-3145-117-90-154-79-155-32-13311-1114-5,930-3-85
000000000000000000000000000000
00000-00.010-0.01-0.010000.090.01-0.11000000.35000005.03-0.8-0.9
00050000205111658413-4-227-117-436-99-119-112-125-161118-6450
0000.050-00.010-00.0400.010.010.090.02-0.110.02-0-00.03-0.12-0.08-0.09-0.12-0.11-0.13-0.215.11-0.86-0.84
000000000-10001302011156000-46-3100
000000000000000000000000000000
22048-4214-1525-183703313-1886110-136-568-63-158890113124320-88-46389
0.80.8-1.4-1.3-7.62.8-8.36.95.730.59.41.719-32.413.4221.356.4-15.182.6191.7137.1229.8216.6338.4220.2361.9516.9735.3421.11,020.34
000000000000000000000000000000

ICON stock margins

The ICON margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ICON. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ICON.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the ICON's sales revenue. A higher gross margin percentage indicates that the ICON retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the ICON's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the ICON's total revenue generated. When comparing the revenue margin year over year, investors can gauge the ICON's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the ICON. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the ICON's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

ICON Margin History

ICON Gross marginICON Profit marginICON EBIT marginICON Profit margin
2029e29.65 %0 %16.97 %
2028e29.65 %20.97 %16.98 %
2027e29.65 %20.78 %16.37 %
2026e29.65 %20.14 %16.2 %
2025e29.65 %19.83 %15.49 %
2024e29.65 %19.55 %14.69 %
202329.65 %12.88 %7.54 %
202228.66 %11.19 %6.53 %
202127.56 %11.09 %2.8 %
202029.31 %14.64 %11.88 %
201929.64 %15.45 %13.33 %
201829.96 %14.87 %12.43 %
201741.58 %19.68 %16.01 %
201642.32 %19.2 %15.73 %
201542.29 %17.87 %15.21 %
201439.92 %14.05 %11.47 %
201336.72 %9.74 %7.69 %
201235.63 %6.6 %4.97 %
201135.3 %4.15 %2.42 %
201039.86 %10.23 %9.68 %
200942.79 %13.1 %10.62 %
200843.46 %11.5 %9.03 %
200743.79 %10.97 %8.88 %
200643.74 %10.49 %8.41 %
200545 %9.15 %4.13 %
200445.27 %11.59 %8.66 %

ICON Stock Sales Revenue, EBIT, Earnings per Share

The ICON earnings per share therefore indicates how much revenue ICON has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue ICON earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates ICON's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of ICON’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating ICON's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

ICON Revenue, EBIT and net profit per share

DateICON Sales per ShareICON EBIT per shareICON Earnings per Share
2029e150.02 undefined0 undefined25.47 undefined
2028e141.98 undefined0 undefined24.11 undefined
2027e132.56 undefined0 undefined21.7 undefined
2026e120.97 undefined0 undefined19.6 undefined
2025e113.28 undefined0 undefined17.54 undefined
2024e104.76 undefined0 undefined15.39 undefined
202398.17 undefined12.64 undefined7.4 undefined
202293.84 undefined10.5 undefined6.12 undefined
202180.48 undefined8.93 undefined2.25 undefined
202052.48 undefined7.68 undefined6.23 undefined
201951.67 undefined7.98 undefined6.89 undefined
201847.37 undefined7.04 undefined5.89 undefined
201732.09 undefined6.32 undefined5.14 undefined
201629.55 undefined5.67 undefined4.65 undefined
201526.12 undefined4.67 undefined3.97 undefined
201423.82 undefined3.35 undefined2.73 undefined
201321.45 undefined2.09 undefined1.65 undefined
201218.43 undefined1.22 undefined0.92 undefined
201115.48 undefined0.64 undefined0.37 undefined
201014.85 undefined1.52 undefined1.44 undefined
200914.82 undefined1.94 undefined1.57 undefined
200814.37 undefined1.65 undefined1.3 undefined
200710.6 undefined1.16 undefined0.94 undefined
20067.9 undefined0.83 undefined0.66 undefined
20055.77 undefined0.53 undefined0.24 undefined
20045.42 undefined0.63 undefined0.47 undefined

ICON business model

ICON PLC is a global company specializing in clinical research and development of pharmaceuticals. The company was founded in 1990 and is headquartered in Dublin, Ireland. It was formed through the merger of several smaller companies. Today, ICON PLC is one of the world's leading companies in the field of clinical trials. ICON is one of the most popular companies on Eulerpool.com.

ICON SWOT Analysis

Strengths

ICON PLC has established a strong global presence in the pharmaceutical and biotechnology industry, gaining a reputation as a trusted partner in clinical research and development.

The company offers a wide range of services including clinical trial management, data management, laboratory services, and consulting, enabling clients to streamline their drug development processes.

ICON PLC has a strong focus on technological advancements, leveraging innovative tools and technologies to improve the efficiency and accuracy of clinical trials and data analysis.

Weaknesses

ICON PLC's revenue is heavily reliant on a few key clients, which poses a risk to the company's financial stability in case of potential loss or reduced business from these clients.

The company's service offerings are primarily focused on clinical research and development, leaving it susceptible to changes in the pharmaceutical industry and potential shifts in client demands.

Opportunities

With the increasing global healthcare expenditure and demand for innovative treatments, ICON PLC can capitalize on the growing market by expanding its services and targeting emerging markets.

Continuous advancements in technology, such as the use of artificial intelligence and big data analytics, present opportunities for ICON PLC to enhance its service offerings, improve operational efficiency, and deliver more accurate insights to its clients.

Threats

The pharmaceutical industry is subject to strict regulatory requirements that can impact the speed and cost of drug development. Non-compliance or changes in regulations pose threats to ICON PLC's operations and profitability.

The industry is highly competitive, with numerous players offering similar services. ICON PLC faces the risk of losing market share to competitors who may offer more cost-effective or innovative solutions.

ICON Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

ICON historical P/E ratio, EBIT, and P/S ratio.

ICON shares outstanding

The number of shares was ICON in 2023 — This indicates how many shares 82.718 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue ICON earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates ICON's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of ICON’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating ICON's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

ICON Stock splits

In ICON's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for ICON.

ICON latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20243.75 3.75  (-0.04 %)2024 Q2
3/31/20243.48 3.47  (-0.32 %)2024 Q1
12/31/20233.51 3.46  (-1.43 %)2023 Q4
9/30/20233.34 3.3  (-1.33 %)2023 Q3
6/30/20233.14 3.11  (-0.87 %)2023 Q2
3/31/20232.93 2.9  (-1.12 %)2023 Q1
12/31/20223.11 3.13  (0.57 %)2022 Q4
9/30/20223 3  (0.02 %)2022 Q3
6/30/20222.85 2.86  (0.32 %)2022 Q2
3/31/20222.75 2.76  (0.31 %)2022 Q1
1
2
3
4
5
...
8

Eulerpool ESG Scorecard© for the ICON stock

Eulerpool World ESG Rating (EESG©)

71/ 100

🌱 Environment

82

👫 Social

99

🏛️ Governance

32

Environment

Scope 1 - Direct Emissions
2,388
Scope 2 - Indirect emissions from purchased energy
15,155
Scope 3 - Indirect emissions within the value chain
14,558
Total CO₂ emissions
17,543
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
✅
Water consumption and efficiency
❌

Social

Percentage of female employees72.434
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

ICON list of shareholders

%
Name
Stocks
Change
Date
8.29495 % WCM Investment Management6,869,881-725,09112/31/2023
6.24872 % MFS Investment Management5,175,193-441,06512/31/2023
4.13839 % Wellington Management Company, LLP3,427,41575,88512/31/2023
3.33425 % Lazard Asset Management, L.L.C.2,761,425-284,57512/31/2023
3.22595 % Boston Partners2,671,730-215,09712/31/2023
3.19372 % Fidelity Management & Research Company LLC2,645,041-102,12612/31/2023
3.13152 % Ninety One UK Limited2,593,526-4,07512/31/2023
3.08340 % Capital Research Global Investors2,553,673530,54812/31/2023
1.92945 % Templeton Investment Counsel, L.L.C.1,597,97124,69412/31/2023
1.86406 % Comgest S.A.1,543,8111,56412/31/2023
1
2
3
4
5
...
10

ICON Executives and Management Board

Dr. Stephen Cutler62
ICON Chief Executive Officer, Director (since 2014)
Compensation 10.03 M
Mr. Brendan Brennan44
ICON Chief Financial Officer
Compensation 2.64 M
Mr. Ciaran Murray
ICON Non-Executive Independent Chairman of the Board (since 2005)
Compensation 630,000
Mr. Ronan Murphy65
ICON Lead Independent Director
Compensation 350,000
Mr. Eugene Mccague
ICON Independent Director
Compensation 325,000
1
2

Most common questions regarding ICON

What values and corporate philosophy does ICON represent?

ICON PLC is a leading global provider of clinical research services to pharmaceutical, biotechnology, and medical device industries. ICON PLC is guided by a set of core values and corporate philosophy that focuses on innovation, integrity, collaboration, and excellence. The company's commitment to delivering high-quality research and development solutions, while maintaining ethical practices, has made it a trusted partner for successful clinical trials. With its dedication to advancing healthcare and improving patient outcomes, ICON PLC continues to be a respected and influential player in the industry.

In which countries and regions is ICON primarily present?

ICON PLC is primarily present in various countries and regions globally. With a strong international presence, the company operates in multiple key markets, including the United States, United Kingdom, Ireland, Europe, Asia-Pacific, and the Middle East. This global footprint enables ICON PLC to cater to clients worldwide and deliver its comprehensive range of professional services.

What significant milestones has the company ICON achieved?

ICON PLC, a leading clinical research organization, has achieved significant milestones throughout its history. The company's accomplishments include becoming a key player in the development and execution of clinical trials worldwide. ICON PLC has successfully expanded its global footprint, delivering exceptional services in over 100 countries. With a strong focus on innovation and technology, the company has pioneered industry-leading solutions to enhance clinical trial processes and improve patient outcomes. ICON PLC's dedication to excellence has resulted in numerous accolades and recognition within the pharmaceutical and biotechnology industries. By consistently delivering high-quality results and establishing strategic partnerships, ICON PLC has solidified its reputation as a trusted and influential player in the field of clinical research.

What is the history and background of the company ICON?

ICON PLC, also known as ICON, is a well-established global provider of clinical research and development services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1990 in Dublin, Ireland, ICON has since expanded its operations worldwide, with offices in over 40 countries. The company offers various services, including clinical trial management, data management and analysis, regulatory support, and post-market surveillance. With a strong focus on innovation and expertise, ICON has successfully collaborated with numerous healthcare organizations to accelerate the development of innovative therapies and improve patient outcomes. Due to its vast experience and industry reputation, ICON PLC continues to be a trusted partner in advancing healthcare solutions globally.

Who are the main competitors of ICON in the market?

The main competitors of ICON PLC in the market include other Contract Research Organizations (CROs) such as Covance Inc., QuintilesIMS Holdings Inc., and PAREXEL International Corporation. These companies provide similar services and solutions in the clinical research and development industry, offering competition to ICON PLC's global presence and expertise.

In which industries is ICON primarily active?

ICON PLC is primarily active in the pharmaceutical, biotechnology, and medical device industries.

What is the business model of ICON?

The business model of ICON PLC is centered around providing clinical research services to pharmaceutical, biotechnology, and medical device companies. ICON offers a range of services including clinical trial management, data collection and analysis, regulatory consulting, and patient recruitment. They help their clients with the development and commercialization of new drugs and treatments by conducting clinical trials and ensuring regulatory compliance. With a strong focus on innovation and expertise in the field, ICON PLC has established itself as a trusted partner for the life sciences industry.

What is the P/E ratio of ICON 2024?

The ICON P/E ratio is 19.63.

What is the P/S ratio of ICON 2024?

The ICON P/S ratio is 2.88.

What is the AlleAktien quality score of ICON?

The AlleAktien quality score for ICON is 8/10.

What is the revenue of ICON 2024?

The expected ICON revenue is 8.68 B USD.

How high is the profit of ICON 2024?

The expected ICON profit is 1.27 B USD.

What is the business model of ICON

ICON plc is a leading global company in the field of clinical research and development of pharmaceuticals. It offers a wide range of services in clinical trials, consulting, strategy development, laboratory analysis, and data management. The company is divided into three main business areas: clinical development services, laboratory analysis, and data management. It works closely with its customers and partners to develop groundbreaking medications and treatments. ICON is known for its Enterprise Laboratory Information Management System (LIMS) and EDC solutions. It has a robust business model and is well-positioned for future growth.

What is the ICON dividend?

ICON pays a dividend of 0 USD distributed over payouts per year.

How often does ICON pay dividends?

The dividend cannot currently be calculated for ICON or the company does not pay out a dividend.

What is the ICON ISIN?

The ISIN of ICON is IE0005711209.

What is the ICON WKN?

The WKN of ICON is 932242.

What is the ICON ticker?

The ticker of ICON is ICLR.

How much dividend does ICON pay?

Over the past 12 months, ICON paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ICON is expected to pay a dividend of 0 USD.

What is the dividend yield of ICON?

The current dividend yield of ICON is .

When does ICON pay dividends?

ICON pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ICON?

ICON paid dividends every year for the past 0 years.

What is the dividend of ICON?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ICON located?

ICON is assigned to the 'Health' sector.

Wann musste ich die Aktien von ICON kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ICON from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did ICON pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of ICON in the year 2023?

In the year 2023, ICON distributed 0 USD as dividends.

In which currency does ICON pay out the dividend?

The dividends of ICON are distributed in USD.

All fundamentals about ICON

Our stock analysis for ICON Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ICON Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.